American Sterilizer Co. v. Sybron Corp.

526 F.2d 542, 188 U.S.P.Q. (BNA) 97, 1975 U.S. App. LEXIS 12026
CourtCourt of Appeals for the Third Circuit
DecidedNovember 7, 1975
DocketNos. 75-1305, 75-1306
StatusPublished
Cited by15 cases

This text of 526 F.2d 542 (American Sterilizer Co. v. Sybron Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Sterilizer Co. v. Sybron Corp., 526 F.2d 542, 188 U.S.P.Q. (BNA) 97, 1975 U.S. App. LEXIS 12026 (3d Cir. 1975).

Opinion

GARTH, Circuit Judge.

May a patent licensee challenge the scope and validity of the underlying patent without first terminating its license agreement? The district court answered this question in the negative by holding that the licensee’s failure to exercise the termination provision in the agreement prevented an attack upon the underlying patent. We reverse, holding that Lear, Inc. v. Adkins, 395 U.S. 653, 89 S.Ct. 1902, 23 L.Ed.2d 610 (1969) controls.

I. FACTS

Each of the parties to this action manufactures and sells gas sterilization apparatus used in modern hospitals. Defendant Sybron Corporation (Sybron), a New York Corporation, owns the McDonald patent1 which was issued in 1962 to Castle Company (Castle), a division of Sybron. For many years prior to 1962, plaintiff American Sterilizer Company (Amsco), a Pennsylvania corporation, made and sold gas sterilizers independent of any equipment made by Castle.

In 1962 Amsco was marketing a product known as the Cryotherm Sterilizer. Castle claimed that the Cryotherm Sterilizer infringed upon its McDonald patent. As a result of this dispute, Amsco, on July 22, 1964, entered into a nonexclusive license agreement with Castle under the McDonald patent.

The license agreement required Amsco to pay royalties to Castle for the sale of sterilizers equipped with the McDonald process as defined in the contract. Dur[544]*544ing the existence of the license, Amsco “acknowledge[d] the validity of said patents.” In addition, the termination provisions of the agreement provided in paragraph 10 that

Amsco may terminate this agreement on thirty (30) days notice in writing to Castle and payment in full of the accrued royalty and thereafter Amsco shall stand in the same position as to the said patents covered by this Agreement as though this Agreement had not been made.

Thereafter, Amsco developed a new sterilizer known as the Medallion. Sybron, as Castle’s successor, asserted that the Medallion process came within the license agreement and claimed royalties due on its sale. Denying that the Medallion process infringed the McDonald patent or came within the license agreement, Amsco refused to pay any royalties, thereby giving rise to this action.

II. PROCEDURAL HISTORY

On December 29, 1969 Amsco filed its original complaint against Sybron and Castle in the United States District Court for the Western District of Pennsylvania.2 Among other relief sought was a judgment declaring the McDonald patent invalid and a judgment that the Medallion process did not infringe the McDonald patent. Thereafter, in order to obtain additional relief, Amsco amended its complaint seeking a declaration that the Medallion process was outside the scope of the 1964 license agreement. The amended complaint, filed on May 25, 1970, accordingly alleged in Count I that the McDonald patent was invalid, in Count II that the McDonald patent did not cover the Medallion process, and in Count III that the Medallion process did not come within the license agreement.3 At all times, up to and including the present, Amsco has refused to terminate the license agreement as provided in paragraph 10 of that agreement. (See pp. 543-544, supra).

On January 7, 1971 the parties, with the court’s approval, entered into a stipulation limiting trial, at that time, to the third count of Amsco’s amended complaint — that the Medallion sterilizer was not subject to the license agreement. The stipulation provided that

[t]he sole issue to be tried at this time by. the Court is whether the plaintiff’s Medalion [sic] Cycle comes within the aforesaid license agreement without prejudice to either party to the raising of other issues following the disposition by the Court of this issue.

Following the stipulation Sybron, without answering the first two counts of Amsco’s amended complaint, answered Count III. In its answer Sybron claimed by way of counterclaim that it was entitled to a full accounting for all royalties due on the sale of Medallion sterilizers. Amsco answered the counterclaim by asserting as affirmative defenses the same two claims as appear in the first two counts of its amended complaint, i. e., a challenge to the patent’s validity (Count I) and to the patent’s scope (Count II).

After a trial to the court, the district court filed its opinion on May 26, 1974 holding that the Medallion process came within the license agreement and directing that judgment be entered against Amsco on Count III of the amended complaint. The court also ordered the entry of a judgment for Sybron on the counterclaim in an amount to be determined after a hearing on damages.

From May, 1974 to January, 1975, Amsco, through various motions, attempted on at least three different occasions to [545]*545raise the issues of the patent’s validity and scope. These attempts were unavailing, as all of Amsco’s motions were dismissed by the court’s order of January 24, 1975. That order also dismissed all counts of the amended complaint except Count III and granted Sybron a judgment on its counterclaim in the amount of $560,508, consisting of the principal sum of $469,409 for royalties due and interest to January 23, 1975.4

Amsco appeals from the entire judgment of January 24, 1975. Sybron appeals from so much of the judgment as pertains to damages, claiming that the court erred in its calculations. Our jurisdiction is predicated upon 28 U.S.C. § 1291.

III. APPLICABILITY OF THE LEAR DOCTRINE

The district court prevented Amsco from challenging the validity and scope of the McDonald patent. It achieved this result by dismissing all counts of the amended complaint except for Count III and by dismissing Amsco’s motions which sought to raise validity and scope as essential issues.

The district court explained in its January 23, 1975 opinion:

At the last hearing held today, January 23, 1975, the Court inquired of plaintiff’s counsel as to whether it has terminated the license agreement. Plaintiff’s counsel was informed that, if it had terminated the license agreement, then the motion to amend the Amended Complaint, filed October 23, last, would be granted, and we would proceed to try validity. Nevertheless, plaintiff’s counsel persists in the contention that under the facts of this case plaintiff is entitled to try validity even though it has not repudiated the license. It is the view of this Court that plaintiff’s position is untenable. The legal principle enforced for many years that a license [sic] cannot challenge the validity of the patent under which he holds his license has application in this case and is the reason for the dismissal of all counts in the Amended Complaint except Count III.

The court’s reliance upon the doctrine of licensee estoppel — that a patent licensee cannot challenge the underlying patent during the term of the license — would require, if we agreed with the district court, a holding that Lear, Inc. v. Adkins, 395 U.S. 653, 89 S.Ct.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
526 F.2d 542, 188 U.S.P.Q. (BNA) 97, 1975 U.S. App. LEXIS 12026, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-sterilizer-co-v-sybron-corp-ca3-1975.